Published in

Taylor and Francis Group, Expert Review of Vaccines, 1(22), p. 378-392, 2023

DOI: 10.1080/14760584.2023.2204154

Links

Tools

Export citation

Search in Google Scholar

Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (Bnt162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses

Journal article published in 2023 by Patrick Dmc Katoto ORCID, Mireille Am Kakubu, Jacques L. Tamuzi, Amanda S. Brand, Adaeze Ayuk, Liliane N. Byamungu, Charles S. Wiysonge ORCID, Glenda Gray
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO